Maryland Cigarette Restitution Fund
12
3
4
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.3%
1 terminated/withdrawn out of 12 trials
87.5%
+1.0% vs industry average
25%
3 trials in Phase 3/4
29%
2 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
A Telenovela Intervention for Caregivers of African-American and Hispanic Hospice Patients
Role: collaborator
C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics
Role: collaborator
C-Raven, a Virtual Tobacco Cessation Intervention in the Community
Role: collaborator
Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity
Role: collaborator
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
Role: collaborator
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
Role: collaborator
Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions
Role: collaborator
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression
Role: collaborator
Survivorship Promotion In Reducing IGF-1 Trial
Role: collaborator
Behavioral Weight Loss Program for Cancer Survivors in Maryland
Role: collaborator
Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer
Role: collaborator
Inpatient Screening Mammography for Non-adherent and High Risk Women
Role: collaborator
All 12 trials loaded